SCHEMBL349819

SCHEMBL349819

[NH]C(=O)c1cc(Cl)cc(Cl)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TPMT P51580 1/20 0.59
HCAR1 Q9BXC0 1/20 0.44
TSHR P16473 1/20 0.44
RXRA P19793 2/20 0.41
RXRB P28702 2/20 0.41
RAB9A P51151 1/20 0.41
FLT1 P17948 1/20 0.38
FLT4 P35916 1/20 0.38
KDR P35968 1/20 0.38
FABP4 P15090 1/20 0.38
HCAR2 Q8TDS4 1/20 0.38
PARP1 P09874 1/20 0.38
ATM Q13315 1/20 0.37
TTR P02766 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
XBP1 P17861 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4465360 0.77 TPMT (0.65) TPMTHCAR1TSHRRXRARXRB
SCHEMBL7495444 0.76 HPGD (0.43) TPMTTSHRRAB9ATTRMEN1
SCHEMBL4091956 0.76 TSHR (0.57) TPMTHCAR1TSHRRXRARXRB
SCHEMBL2486695 0.75 PARP1 (0.63) RAB9AFLT1FLT4KDRPARP1
SCHEMBL28214359 0.74 TPMT (1.00) TPMTHCAR1TSHRRXRARXRB
SCHEMBL19998298 0.74 TPMT (0.62) TPMTHCAR1TSHRRXRARXRB
SCHEMBL93282 0.74 TPMT (0.62) TPMTHCAR1TSHRRXRARXRB
SCHEMBL2170895 0.74 TPMT (0.62) TPMTHCAR1TSHRRXRARXRB
SCHEMBL69625 0.74 TPMT (0.89) TPMTHCAR1TSHRRXRARXRB
SCHEMBL23699 0.74 TPMT (1.00) TPMTHCAR1TSHRRXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060058553-A1 Novel bicyclic hydroxamates as inhibitors of histone deacetylase AXYS PHARMACEUTICALS, INC. (US) 2006-03-16 US claimed
EP-1472216-A2 NOVEL BICYCLIC HYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE Axys Pharmaceuticals (US) 2004-11-03 EP claimed
WO-2003066579-A2 NOVEL BICYCLIC HYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE AXYS PHARMACEUTICALS (US) 2003-08-14 WO claimed
US-20030055096-A1 Fungicidal composition OGURI YUKIO (JP) 2003-03-20 US claimed
EP-0741970-B1 BACTERICIDAL COMPOSITION SUMITOMO CHEMICAL CO (JP) 2002-04-24 EP claimed
EP-0793914-B1 Fungicidal Composition SUMITOMO CHEMICAL CO (JP) 1999-09-15 EP claimed
EP-0793914-A1 Microbicidal Composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1997-09-10 EP claimed
EP-0741970-A1 BACTERICIDAL COMPOSITION SUMITOMO CHEMICAL COMPANY LIMITED (JP) 1996-11-13 EP claimed
EP-0096307-B1 FUNGICIDAL COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1987-01-07 EP claimed
EP-0096307-A1 Fungicidal composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1983-12-21 EP claimed
JP-61063607-A None JP disclosed
JP-9241110-A None JP disclosed
JP-58208201-A None JP disclosed
JP-63002907-A None JP disclosed
US-8404036-B2 Water-soluble near-infrared absorbing coloring matters and aqueous inks containing same NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-03-26 US disclosed
JP-S6163607-A AGRICULTURAL AND HORTICULTURAL FUNGICIDAL COMPOSITION SUMITOMO CHEM CO LTD 1986-04-01 JP disclosed
EP-0096307-A1 Fungicidal composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1983-12-21 EP disclosed
EP-0096307-A1 Fungicidal composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1983-12-21 EP disclosed
JP-S58208201-A AGRICULTURAL AND HORTICULTURAL GERMICIDAL COMPOSITION SUMITOMO CHEM CO LTD 1983-12-03 JP disclosed
US-4009278-A Antimicrobial composition and method containing N-(3,5-dihalophenyl)-imide compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1977-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030055096-A1 Fungicidal composition CBR1, CBR3, CYP1B1 TPMT 1243/4885HCAR1 2740/4885TSHR 1948/4885
US-20060058553-A1 Novel bicyclic hydroxamates as inhibitors of histone deacetylase HDAC1, HDAC2, HDAC11 TPMT 2626/4885HCAR1 157/4885TSHR 3583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.